Compound ID | 1341
Class: Beta-lactam (penicillin)
Spectrum of activity: | Gram-negative |
Details of activity: | Beta-Lactamase resistant. primarily for the treatment of multiple drug-resistant, Gram-Negative bacteria. Not active against Gram-positive bacteria or bacteria with altered penicillin-binding proteins |
Institute where first reported: | Beecham Pharmaceuticals (GSK, US) |
Year first mentioned: | 1982 |
Highest developmental phase: | Phase 4 |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/171758 |
Guide to Pharmacology: | temocillin |
Citations: |
|